What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Diabetes mellitus
Maciej Banach mainly focuses on Internal medicine, Disease, Intensive care medicine, Endocrinology and Statin. His research integrates issues of Gastroenterology and Cardiology in his study of Internal medicine. His work in Intensive care medicine covers topics such as Dyslipidemia which are related to areas like Nutraceutical.
His study looks at the intersection of Endocrinology and topics like Bioinformatics with Liver X receptor. As part of the same scientific family, Maciej Banach usually focuses on Statin, concentrating on Adverse effect and intersecting with Regimen. His work deals with themes such as Meta-analysis, Randomized controlled trial and Urology, which intersect with Confidence interval.
His most cited work include:
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 (2508 citations)
- Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults (2180 citations)
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017 (1735 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Cardiology, Endocrinology, Meta-analysis and Randomized controlled trial. His research brings together the fields of Gastroenterology and Internal medicine. His Cardiology research includes elements of Stroke and Blood pressure.
His research links Disease with Endocrinology. His studies deal with areas such as Placebo and Clinical trial as well as Meta-analysis. In his research, Pharmacology is intimately related to Statin, which falls under the overarching field of Randomized controlled trial.
He most often published in these fields:
- Internal medicine (80.61%)
- Cardiology (22.45%)
- Endocrinology (21.87%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (80.61%)
- Disease (17.23%)
- Pharmacology (14.91%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Disease, Pharmacology, Cardiology and Randomized controlled trial are his primary areas of study. His Internal medicine research incorporates themes from Diabetes mellitus, Endocrinology and Mendelian randomization. His study in Disease is interdisciplinary in nature, drawing from both Epidemiology and Intensive care medicine.
Maciej Banach has included themes like Statin and PCSK9 in his Pharmacology study. The Randomized controlled trial study combines topics in areas such as Nutraceutical, Telerehabilitation and Good manufacturing practice. His Environmental health research integrates issues from Global health and Incidence.
Between 2019 and 2021, his most popular works were:
- Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (401 citations)
- Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (224 citations)
- Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (163 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
His scientific interests lie mostly in Internal medicine, Disease, Confidence interval, Pharmacology and Ezetimibe. Internal medicine and Endocrinology are commonly linked in his work. His Disease study combines topics from a wide range of disciplines, such as Global health, Epidemiology and Intensive care medicine.
His work in Confidence interval tackles topics such as Diabetes mellitus which are related to areas like Propensity score matching, Lycopene, Anthropometry, Relative risk and C-reactive protein. His Pharmacology study integrates concerns from other disciplines, such as Renin–angiotensin system, LDL Cholesterol Lipoproteins, Pravastatin and Secondary prevention. Maciej Banach combines subjects such as Stroke and Prospective cohort study with his study of Meta-analysis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
